CoreWeave, Inc. Securities Fraud Class Action Result of Undisclosed Deployment Issues and 20% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

(NASDAQ:CRWV), NEW YORK and NEW ORLEANS, Jan. 20, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against CoreWeave, […]

CoreWeave, Inc. Securities Fraud Class Action Result of Undisclosed Deployment Issues and 20% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

CoreWeave, Inc. Securities Fraud Class Action Result of Undisclosed Deployment Issues and 20% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC GlobeNewswire January 21, 2026 NEW YORK and NEW ORLEANS, Jan. 20, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General

Selling the 518 TV Series Spotlights New York’s Capital Region on REAL Shows Network

REAL Shows Network (RSN), the national TV platform dedicated to elevating real estate and lifestyle storytelling, has added Selling the 518, a new locally hosted series in New York’s Capital Region, to its lineup. Hosted by local real estate leader Rebecca Cavalieri and produced by RSN’s Emmy-nominated, Telly Award-winning team, the show shines a spotlight

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Bitdeer Technologies Group Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTDR

New York, New York–(Newsfile Corp. – January 20, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitdeer Technologies Group (NASDAQ: BTDR) between June 6, 2024 and November 10, 2025, both dates inclusive (the “Class Period”), of the important February 2, 2026 lead plaintiff deadline. SO WHAT: If

CHINA WORLD SUMMIT WING, BEIJING: A PREMIER URBAN LIFESTYLE DESTINATION AT THE PEAK OF BEIJING

China World Summit Wing, Beijing has redefined urban luxury with its positioning as an Urban Lifestyle Destination. This iconic hotel stands as both Destination and Social Hub for Celebration in Beijing's bustling CBD, offering unparalleled experiences that cater to the discerning tastes of elites all around the globe. This year, the hotel's Hallmark Experiences has

LEPAS Opens Its World’s First Showroom in Indonesia, Ushering in a New Chapter in the NEV Market

On January 19, LEPAS, the all-new NEV brand under Chery Group, officially opened its World’s First Showroom in Jakarta, Indonesia. More than a hundred attendees, including Indonesian government representatives, media, KOLs, and dealership partners, gathered to witness this milestone in the brand’s expansion journey. At the event, representatives from the Indonesian government, several executives from

F5, Inc. Securities Fraud Class Action Result of Data Breach and 24% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

(NASDAQ:FFIV), NEW YORK and NEW ORLEANS, Jan. 20, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5,

F5, Inc. Securities Fraud Class Action Result of Data Breach and 24% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

F5, Inc. Securities Fraud Class Action Result of Data Breach and 24% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC GlobeNewswire January 21, 2026 NEW YORK and NEW ORLEANS, Jan. 20, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of

HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is a leading research institute focused on conducting clinical trials in hepatology and gastroenterology, with a special emphasis on metabolic liver disease. The institute delivers high-quality research that complements the medical care

HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is a leading research institute focused on conducting clinical trials in hepatology and gastroenterology, with a special emphasis on metabolic liver disease. The institute delivers high-quality research that complements the medical care

Scroll to Top